000			02000 a2200505 4500
005			20250516012145.0
264		0	_c20110120
008			201101s 0 0 eng d
022			_a1527-7755
024	7		_a10.1200/JCO.2010.30.9674 _2doi
040			_aNLM _beng _cNLM
100	1		_aFox, Elizabeth
245	0	0	_aA phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cDec 2010
300			_a5174-81 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdolescent
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aArea Under Curve
650	0	4	_aChild
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aQuinazolines _xadministration & dosage
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors
700	1		_aAplenc, Richard
700	1		_aBagatell, Rochelle
700	1		_aChuk, Meredith K
700	1		_aDombi, Eva
700	1		_aGoodspeed, Wendy
700	1		_aGoodwin, Anne
700	1		_aKromplewski, Marie
700	1		_aJayaprakash, Nalini
700	1		_aMarotti, Marcelo
700	1		_aBrown, Kathryn H
700	1		_aWenrich, Barbara
700	1		_aAdamson, Peter C
700	1		_aWidemann, Brigitte C
700	1		_aBalis, Frank M
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 28 _gno. 35 _gp. 5174-81
856	4	0	_uhttps://doi.org/10.1200/JCO.2010.30.9674 _zAvailable from publisher's website
999			_c20358540 _d20358540